Rare diseases
Investigational molecules
Locations
453 conditions with trials, the busiest first
1 389 trials across Europe, recruiting first
Study on Galcanezumab for Preventing Episodic Migraine in Children and Teens Aged 6 to 17
DenmarkStudy on Galcanezumab for Preventing Chronic Migraine in Adolescents Aged 12 to 17
DenmarkStudy on the Safety of Tenofovir Alafenamide and Natalizumab for People with Multiple Sclerosis
NorwayStudy on JDQ443 for Patients with KRAS G12C+ Non-Small Cell Lung Cancer and Brain Metastases
The NetherlandsStudy on Cannabidiol Oral Solution for Infants with Tuberous Sclerosis, Dravet Syndrome, or Lennox-Gastaut Syndrome Experiencing Uncontrolled Seizures
ItalyStudy on the Long-term Safety and Effects of AL002 and Florquinitau F18 in Patients with Alzheimer's Disease
FranceStudy on Larotrectinib for Treating Children with Advanced Solid Tumors with NTRK Fusion
CzechiaStudy on the Effect of Botulinum Toxin Type A and Physiological NaCl 0.9% in Patients with Piriformis Syndrome
The NetherlandsStudy on the Safety and Effects of Ocrelizumab for Children and Adolescents with Relapsing-Remitting Multiple Sclerosis
ItalyStudy of Naxitamab and Sargramostim for High-Risk Neuroblastoma in Patients with Refractory Bone or Bone Marrow Disease
DenmarkStudy on the Safety and Effectiveness of Mirabegron for Children Aged 6 Months to Under 3 Years with Neurogenic Detrusor Overactivity
BelgiumStudy on the Safety and Effects of Risdiplam for Adults and Children with Spinal Muscular Atrophy
BelgiumThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
